The Pharmaceutical Market: Slovenia
Opportunities and Challenges
| Publication Date | September 2009 |
|---|---|
| Publisher | Espicom |
| Product Type | Report |
| Pages | 72 |
| ISBN Number | not applicable |
| Product Code | ESP00290 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Includes 3 quarterly updated outlook reports!
The population of Slovenia is estimated at 2.0 million in 2009 and is slowly ageing; 16.8% of Slovenians are currently aged 65, compared to 14.1% in 2000. Slovenia is one of the richest CEE countries and successfully joined the EU in May 2004. It became the first new member state to adopt the Euro in January 2007.
Funding for healthcare in Slovenia is primarily through compulsory health insurance. The system was introduced in 1992 and is managed by the Health Insurance Institute of Slovenia. Sources of income for the fund include employers and employees, farmers, the pension fund and the state budget. Those insured are entitled to free health services, sick pay and reimbursement of travel expenses linked to obtaining health services.
In 2009, the Slovenian market for pharmaceuticals is estimated at US$1,505 million, or US$749 per capita. It is expected that the market will continue to expand at a rate of 8.6% per annum, reaching US$2,277 million, equal to US$1,138 per capita, by 2014. Around 38% of the pharmaceutical market is supplied by imports. Germany and Austria were the leading suppliers in 2008, accounting for 43.4% of imports. The value of imports has increased every year since 1999. However, there was a fall of -6.0% in 2007.
Slovenia is home to Krka and Lek, the two largest generics companies in Central and Eastern Europe. Lek has been owned by Novartis since 2002. In 2006, these companies recorded total sales of US$1,639 million. However, only 10.7% of these sales were domestic. Both companies export a large proportion of their products to Central and Eastern Europe. Lek has also strengthened its position in the US market by launching its omeprazole product, which had previously been available only in its traditional European markets.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.
Content
GEOGRAPHYPOLITICAL OVERVIEW
ECONOMIC OVERVIEW
Economic Indicators, 1995-2012
POPULATION
Population as of 31st December, 1995-2007
Population by Region, 2000-2006 (As of 31st December)
Population by Region and Age Group, 31st December 2006
Population by Age Group, 2000-2006 (%)
DEMOGRAPHIC INDICATORS
Principal Demographic Indicators, 1997-2005
MORTALITY
Causes of Death, 2001-2005
MORBIDITY
Reported Infectious Diseases, 2000-2005
HIV/AIDS
Reported Cases of HIV/AIDS, 1999-2005
ORGANISATION & ADMINISTRATION
HEALTH EXPENDITURE
Public Health Expenditure, 1997-2002 (SIT millions)
HOSPITAL SERVICES
Hospitals & Beds 1997-2005
Hospital Activity
Hospital Activity, 1997-2005
AMBULATORY CARE
Clinics
Outpatient Facilities, 1995-1997
Outpatient Visits to Primary Care Facilities by Cause, 2001-2004
Dental Services
Dental Visits, 2004
Number of Dental Treatments by Type, 2001-2004
Hospital Outpatient Care
Hospital Outpatient Visits, 1999-2005
MEDICAL PERSONNEL
Total Medical Personnel, 2000-2004
Medical Personnel by Workplace, 2004
INTRODUCTION
REGULATORY ENVIRONMENT
Pharmaceutical Registration
Advertising
Patent Protection & Intellectual Property Rights
Pricing and Reimbursement
Pricing
Reimbursement
DISTRIBUTION CHANNELS
Distributors
Kemofarmacija d.d.
TRADE FAIRS
Medilab
DOMESTIC PRODUCTION
Domestic Producers
Bayer Pharma
Krka
Krka Financial Results, 1998-2006 (SIT millions)
Lek
Lek Financial Results, 1997-2004 (SIT millions)
DIRECTORY
Government Organisations
Trade Associations
CHARTS
Map of Slovenia
Population by Age Group, 2006 (%)
Birth and Death Rates, 1996-2005
Causes of Death, 2005 (%)
Public Expenditure by Type, 2002 (%)
SLOVENIA
BACKGROUND DATA
GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
Economic Indicators, 1995-2012
POPULATION
Population as of 31st December, 1995-2007
Population by Region, 2000-2006 (As of 31st December)
Population by Region and Age Group, 31st December 2006
Population by Age Group, 2000-2006 (%)
DEMOGRAPHIC INDICATORS
Principal Demographic Indicators, 1997-2005
MORTALITY
Causes of Death, 2001-2005
MORBIDITY
Reported Infectious Diseases, 2000-2005
HIV/AIDS
Reported Cases of HIV/AIDS, 1999-2005
CHARTS
Map of Slovenia
Population by Age Group, 2006 (%)
Birth and Death Rates, 1996-2005
Causes of Death, 2005 (%)
SLOVENIA
HEALTHCARE SYSTEM
ORGANISATION & ADMINISTRATION
HEALTH EXPENDITURE
Public Health Expenditure, 1997-2002 (SIT millions)
HOSPITAL SERVICES
Hospitals & Beds 1997-2005
Hospital Activity
Hospital Activity, 1997-2005
AMBULATORY CARE
Clinics
Outpatient Facilities, 1995-1997
Outpatient Visits to Primary Care Facilities by Cause, 2001-2004
Dental Services
Dental Visits, 2004
Number of Dental Treatments by Type, 2001-2004
Hospital Outpatient Care
Hospital Outpatient Visits, 1999-2005
MEDICAL PERSONNEL
Total Medical Personnel, 2000-2004
Medical Personnel by Workplace, 2004
CHARTS
Public Expenditure by Type, 2002 (%)
SLOVENIA
ACCESSING THE PHARMACEUTICAL MARKET
INTRODUCTION
REGULATORY ENVIRONMENT
Pharmaceutical Registration
Advertising
Patent Protection & Intellectual Property Rights
Pricing and Reimbursement
Pricing
Reimbursement
DISTRIBUTION CHANNELS
Distributors
Kemofarmacija d.d.
TRADE FAIRS
Medilab
DOMESTIC PRODUCTION
Domestic Producers
Bayer Pharma
Krka
Krka Financial Results, 1998-2006 (SIT millions)
Lek
Lek Financial Results, 1997-2004 (SIT millions)
DIRECTORY
Government Organisations
Trade Associations
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories











